Browse
Explore conditions, clinical trials, and the organisations running them.
Find a trial
Search by condition, then narrow by status and aim.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
130005 trials found · Page 6463 of 6501
-
Experimental drug BGB-23339 tested for safety in 92 healthy people
Knowledge-focused CompletedThis study will evaluate the safety, tolerability, and pharmacokinetics of BGB-23339 and food effects in healthy participants
Phase 1 • Sponsor: BeiGene • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Laughing gas for fibromyalgia? study pulled before it began
Symptom relief CancelledThe purpose of this study is to explore a potential role of nitrous oxide in treating pain associated with fibromyalgia.
Phase 2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
COVID-19 antibody drug trial halted early — little data to show
Disease control Stopped earlyPrimary Objectives Phase 1 (Safety and Tolerability) • Evaluate the safety and tolerability of REGN14256+imdevimab and REGN14256 monotherapy, as measured by treatment-emergent adverse events (TEAEs), injection-site reactions (ISRs), and hypersensitivity reactions Phase 1/2 (Vir…
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Brain zaps for suicide prevention? study pulled before starting
Knowledge-focused CancelledThis study evaluates the effects of an accelerated schedule of theta-burst stimulation, termed accelerated intermittent theta-burst stimulation (aiTBS), on the neural networks underlying explicit and implicit suicidal cognition in inpatients with major depressive disorder.
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New pill tested in healthy people: first step toward future treatments
Knowledge-focused CompletedThe main purpose of this study is to conduct blood tests to measure how much LY3502970 is in the bloodstream and how the body handles and eliminates LY3502970 in healthy participants in fed and fasted states. The study will also evaluate the safety and tolerability of LY3502970 i…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New drug KINE-101 tested in humans for first time
Knowledge-focused CompletedThis is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose (SAD) study that evaluates the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of intravenous (IV) and subcutaneous (SC) formulations of KINE-101 in healthy volunteers at…
Phase 1 • Sponsor: Kine Sciences Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Pain relief showdown: injection vs. patch for back and neck pain
Symptom relief CancelledThe aim of this trial is to investigate the efficacy of trigger point injections with 1% lidocaine in reducing myofascial back and neck pain in the Emergency Department compared to lidocaine patches 5%.
Phase 4 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Blueberry brain boost? study planned but never started
Knowledge-focused CancelledIn this randomized placebo controlled intervention study, the effect of 12 weeks of supplementation with either 150g whole blueberries, freeze-dried blueberry powder (dose equivalent to 150g berries) versus placebo on cognitive functioning will be investigated in older adults.
Sponsor: Wageningen University • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:46 UTC
-
Prostate cancer recurrence study pulled before it even started
Knowledge-focused CancelledThe purpose of this study is to learn more about what effects the use of high-dose-rate (HDR) brachytherapy on prostate cancer recurrence, seen by AXUMIN PET scan, has on prostate cancer.
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Common steroid could shield lungs after surgery, but study pulled
Prevention CancelledThoracic surgery is at high risk of respiratory complications. Despite the improvement of surgical procedures such as video-thoracoscopy, respiratory complications appear in 15 to -20% of procedures. Thoracic surgery induces local pulmonary inflammation which is involved in the o…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
Shower power: simple Pre-Surgery cleanliness study halted early
Knowledge-focused Stopped earlyThe aim of the project is to evaluate the effectiveness, on the skin cleanliness of the patient on arrival at the operating room, of an intervention aimed at improving the performance of the preoperative shower, for patients undergoing a planned surgical intervention in an orthop…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
FASD study pulled before it began: oxygen vs. brain games never tested
Disease control CancelledFetal Alcohol Spectrum Disorder (FASD) describes a wide range of adverse physical, behavioral and cognitive effects resulting from prenatal alcohol exposure (PAE) during embryonic and fetal development. A number of clinical studies have presented evidence regarding the physiologi…
Sponsor: Assaf-Harofeh Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Drug interaction check: will fluconazole change how BI 425809 works?
Knowledge-focused CompletedThe main objective of this trial is to investigate the effect of fluconazole, under steady state conditions on the pharmacokinetics of BI 425809 (Reference Treatment R: BI 425809 alone; Test Treatment T: BI 425809 given under steady state conditions of fluconazole).
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New drug BI 3006337 tested in healthy volunteers for safety
Knowledge-focused CompletedThe main objectives of this trial are to investigate safety, tolerability and pharmacokinetics of BI 3006337 in healthy male subjects following subcutaneous administration of single-rising doses.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Thinking while exercising? study reveals how mental effort wears out your muscles
Knowledge-focused CompletedThis study will determine the influence of a cognitive task performed during fatiguing contractions.
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Scientists track cancer Drug's journey through the body
Knowledge-focused CompletedA Phase I, Open-label Study of Absorption-Distribution-Metabolism-Excretion (ADME) of \[14C\]IMP4297 Following a Single Oral Dose to China Healthy Male Subjects
Phase 1 • Sponsor: Impact Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:09 UTC
-
Scientists map out antiviral Drug's journey in tiny human trial
Knowledge-focused CompletedThis open-label, single dose study in approximately 5 healthy male and female (of non childbearing potential only) participants has been designed to characterize mass balance and further the understanding of human pharmacokinetics, metabolism, and excretion of PF 07304814 adminis…
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New dental crowns tested – but trial halted early
Disease control Stopped earlyCAD-CAM crowns made of experimental lithium disilicate (shades A1, A2 and A3) are placed in patients by using either a dual-curing adhesive or a self-adhesive luting material in combination with total etch/universal bonding agent.
Sponsor: Ivoclar Vivadent AG • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Insulin nasal drops pass early safety test in healthy volunteers
Knowledge-focused CompletedThis study is to determine the safety and tolerability of regular insulin (Humulin R) when given intranasally (as drops in nostrils). Healthy participants will be enrolled to determine the maximum tolerated dose of intranasal insulin.
Phase 1 • Sponsor: Robert Silbergleit • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New spray promises lasting hydration for dry skin
Symptom relief CompletedThis study is a monocentric, intra-individual, controlateral design study, on the internal and posterointernal side of the forearms, to evaluate the moisturizing effect of study product AV0018B and of the persistence of this effect after repeated applications for 7 days, compared…
Sponsor: Pierre Fabre Dermo Cosmetique • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC